Inese Cebere

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8⁺T-Cell Epitopes

Nilu Goonetilleke, S. S. Moore, Len Dally et al. · Journal of Virology · 2006 · 236 citations · Full text

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans

Matilu Mwau, Inese Cebere, Julian Sutton et al. · Journal of General Virology · 2004 · 210 citations

Mva.hiva Vaccines, Immunology, Cd4 T Cell Responses +16

Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

Inese Cebere, Lucy Dorrell, Helen McShane et al. · Vaccine · 2005 · 125 citations

Vaccination, Clinical Trial Safety, Healthy Hiv-1-uninfected Volunteers +10

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

Ana Guimarães‐Walker, N Mackie, Sean McCormack et al. · Vaccine · 2008 · 56 citations

Clinical Immunology, Medicine, Human Retrovirus +10

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine

Lucy Dorrell, Hongbing Yang, Astrid K. N. Iversen et al. · AIDS · 2005 · 40 citations

Vaccination, Haart Suppression, Therapeutic Immunization +15